Physician profile
Adil Karim
NPI 1255747986
$608.46
in general payments reported to CMS, 2019-2025
7 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.08 · 2021: $42.71 · 2022: $87.32 · 2024: $310 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $263 · Education: $146 · Gift: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $263.27 |
| Education | $146.08 |
| Gift | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $182.86 | 2024-2025 | Impella |
| Abbott Laboratories | $146.08 | 2024 | Ensite |
| Janssen Pharmaceuticals, INC | $124.02 | 2020-2022 | |
| Medtronic, INC. | $99.47 | 2024 | Cobalt Dr Mri Surescan |
| Penumbra, INC. | $25.09 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.70 | 2025 | Lifevest |
| Terumo Medical Corporation | $14.24 | 2024 | Glidesheath Slender |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adil Karim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.